Filip Wiberg

Stock Analyst at Pareto

(1.17)
# 3,801
Out of 5,099 analysts
3
Total ratings
50%
Success rate
-12.4%
Average return

Stocks Rated by Filip Wiberg

Swedish Orphan Biovitrum AB (publ)
Oct 27, 2026
Upgraded: Buy
Price Target: kr 470.00 → kr 530.00
Current: kr 477.40
Upside: +11.02%
Xvivo Perfusion AB (publ)
Mar 25, 2025
Upgraded: Buy
Price Target: kr 460.00
Current: kr 194.80
Upside: n/a